Citation Bioscience with the slogan ‘We will get through this together’ are making the task of detecting Covid-19 simple with home testing kits that are readily utilizable. These kits endow with a proven method for detecting the commencement of this extremely transmittable disease. It can be purchased online. It is developed in 1101 Kings Hwy N Cherry Hill.
It is an RT-PCR for coronavirus and tested at a CLIA certified lab. If you have sensed COVID viral infection try this COVID test home kit
Why Citation Bioscience?
- RT-PCR test
- They give fast results within 24 hours after the sample received
- Saliva test – Easy to collect sample unlike painful swab test
- No prescription needed
- Cost reimbursable by majority insurance providers
- 100% Safe with No age restrictions to take the test
PCR test kit ingredients:
- A swab
- A vial containing a small amount of liquid –remain in the tube
- A clear zip-lock bag with an absorbent pad
- A bag with a QR code
- 3 stickers
- A box
Have you ever heard of the PCR home test?
Forget about the worries of standing in the long queues, get a home PCR kit of your own with easy return
This kit can be sent to your home or office wherever you want. You can self-sample in your presence, during breaks. It is easy to fill saliva tubes with samples and put the tubes in a biohazard proof box.
You can ship the kits back to us in a pre-labelled shipping bag provided on the pack.Within24 hours results will be mailed to the human resource and to the employees or based on your companies protocol or personal information is given. It helps to make sure that you as employees do not stand in long queues and waste time standing unnecessary for a long period.
Citation bioscience offers one transparent price for the test, without any extra bills ever. The cost of the test is reimbursable with healthcare insurance. Eligible for purchase with HAS & FSA. After your test is done you will receive an itemized receipt so that you can apply for reimbursement directly from your health insurance provider. Always go for a check with your insurance provider to verify benefits coverage. ‘With a pledge, We Will Get Thru This Together’ we will soon come out of this deadly disease.
The COVID-19 Antibody Detection Kit Market 2021 research report gives emerging industry data, global segments and regional outlook.
The report generated using various analysis tools like porter’s five forces model, market attractiveness and value chain.
The report gives comprehensive review of the global market helping to club revenue generation and profitable business to transform client’s success.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the COVID-19 antibody detection kit market include Cellex, Abbott, Roche, BioMedomics, BD, Henry Schein, Safecare Bio-Tech, Others.
This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global COVID-19 Antibody Detection Kit Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/covid-19-antibody-detection-kit-market/download-sampleMarket DynamicsMassively rising cases of coronavirus worldwide will be the main driving factor for the growth of this market.
An increase in government approvals for novel antibody test kits will boost market growth.
We conduct an accurate and reliable COVID Test.
Our qualified phlebotomists trained for safe and hygienic sample collecting during Test for COVID 19.
We are the most trustworthy lab for COVID 19 testing in India.
Get your COVID-19 Test done with Metropolis Healthcare.
Taking care of mental health during COVID 19 is very important.
So, to help you, we present 8 great ways to keep your mental health strong.
COVAXIN is India’s ‘first’ indigenous COVID-19 antibody, created by Hyderabad-based Bharat Biotech in a joint effort with ICMR and NIV.Indian specialists have given the green light to test Bharat Biotech’s COVID-19 antibody in Phase I and Phase II clinical preliminaries.India’s first potential COVID-19 antibody has been given endorsement for Phase I and Phase II clinical preliminaries.
Named COVAXIN™, the immunization was created by Bharat Biotech and has been allowed endorsement from the Drugs Controller General of India (DCGI).
Human clinical preliminaries are booked to begin across India in July 2020Bharat Biotech made COVAXIN in a joint effort with the Indian Council of Medical Research (ICMR) and National Institute of Virology (NIV).
As indicated by the organization, the SARS-CoV-2 strain was confined in NIV, Pune and moved to Bharat Biotech.
The indigenous, inactivated immunization was created and made in Bharat Biotech’s office situated in Hyderabad, India.The DCGI conceded consent to start Phase I and II human clinical preliminaries after the organization submitted results created from pre-clinical investigations, illustrating “promising” and “broad” security and safe reactions.Dr Krishna Ella, Chairman and Managing Director of Bharat Biotech, stated: “We are pleased to declare COVAXIN, India’s first indigenous immunization against COVID-19.
The coordinated effort with ICMR and NIV was instrumental in the improvement of this immunization.The proactive help and direction from CDSCO has empowered endorsements to this task.
